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Many health benefits of millets (defined broadly to also include sorghum) have been
advocated, including their roles in managing and preventing diabetes; however, the
effects of millets on hyperlipidemia (high lipid levels) have been underrecognized. A
systematic review and meta-analysis were conducted to collate available evidence
of the impacts of millets consumption on lipid profile, namely total cholesterol (TC),
triacylglycerol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein
cholesterol (LDL-C), and very-low–density lipoprotein cholesterol (VLDL-C). The results
from 19 studies showed that the consumption of millets for periods as short as 21 days
to 4 months reduced levels of TC, triacylglycerol, LDL-C, and VLDL-C (p<0.01) by 8.0,
9.5, 10 and 9.0%, respectively. Four studies demonstrated that millets consumption
brought TC and triacylglycerol levels to the normal levels (<200 and <150 mg/dl,
respectively). Furthermore, upon consumption of millet-based meals, there was a 6.0%
increase in the HDL-C 4.0 and 5.0% reduction in systolic and diastolic blood pressure,
and 7.0% reduction in body mass index (BMI). This evidence, leads us to conclude that
consumption of millets reduces hyperlipidemia and hence hypertension, and raises the
levels of HDL-C (good cholesterol), which can be beneficial for managing the associated
risk of developing hypertension and atherosclerotic cardiovascular diseases in future.
Systematic Review Registration: The protocol of this systematic review has been
registered in the online registration platform called “research registry” with the unique
identification number “reviewregistry1123.”
Keywords: millets, hyperlipidemia, cholesterol, triacylglycerol, lipid profile
INTRODUCTION
Cardiovascular disease (CVD) is one of the leading causes of morbidity and mortality globally,
accounting for 30% of deaths (1) worldwide, in which blood lipid profile plays a major role.
Elevated levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), very-low–
density lipoprotein-cholesterol (VLDL-C), and triacylglycerol lead to progression of CVD and an
increase of mortality. Among these, LDL-C is a major modifiable risk factor for atherosclerotic
CVD (2), whereas, some types of the high-density lipoprotein cholesterol (HDL-C) are considered
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“good” cholesterol. Therefore, it is important to look at the ratio
of TC to HDL-C in assessing the risk of CVD (3, 4). Along with
lifestyle management, it is also vital to focus on a diet that can
lower the risk of CVD by regulating metabolism and managing
the lipid profile.
In developing countries, cereals typically occupy a major
portion of the nutritionally unbalanced plate, which tends to be
dominated by milled rice, maize, and refined wheat providing
readily available carbohydrates. In addition, the so-called “junk
food” and other unhealthy foods made from refined flour and
fatty ingredients introduce large amounts of saturated fats into
the body which, combined with sedentary lifestyles, can worsen
the health of individuals. Lipid metabolism can be severely
affected in individuals who are pre-diabetic, have type 2 diabetes
mellitus, or other metabolic syndromes. Therefore, diet-based
interventions for diabetes and other metabolic syndromes should
contain ingredients that have a low glycemic index (GI) and the
potential to correct metabolic abnormalities, such as deleterious
lipid metabolism.
Millets are recognized as smart foods (5) as they fulfill
the criteria of being “good for you,” “good for the planet,”
and “good for the farmer,” Millets are traditional nutritious
staple foods which can diversify staples and the overall diet
when introduced, thereby playing a key role in controlling the
levels of lipids in blood, managing metabolic disorders, such as
diabetes and hyperlipidemia, and reducing the potential risk of
developing CVD.
A recent systematic review andmeta-analysis of lowGImillets
(including sorghum) and their effects on managing and reducing
the risk of developing type 2 diabetes shows that millets have
a beneficial effect on various outcomes, such as the fasting and
post-prandial blood glucose levels, insulin index, and glycated
hemoglobin (HbA1c) marker levels (6). This ability to manage
and prevent diabetes may also help toward the management
of hyperlipidemia. However, further, studies are needed to
understand the effects of the consumption of millets on blood
lipid management. This systematic review and meta-analysis
are aimed at collating science-based evidence from randomized
controlled trials and self-controlled clinical trials conducted
through dietary intervention and cross-sectional studies on use
of millets and their effects on lipid profile.
Review question: Does consumption of millet(s)-based foods




The systematic review and meta-analysis were conducted
from October 2017 to March 2021. The protocol of this
systematic review has been registered in the online registration
platform called “research registry” with the unique identification
number “reviewregistry1123.”
Information Sources
The study used the 27-item Preferred Reporting Items for
Systematic Reviews and Meta-analyses (PRISMA) checklist (7)
for every step of data collection, extraction, and analysis.
TABLE 1 | Search strategy and keywords used to identify relevant papers.
Number Criteria and keywords used for search
1 Boolean logic such as “AND,” “OR,” “NOT” were used.
2 Efficacy of millets on lipid profile. Replaced the word “millets” with the
names of millets, such as “barnyard millet,” “foxtail millet,” “finger
millet,” “pearl millet,” “proso millet,” “brown top millet,” “little millet,”
“kodo millet,” “teff,” “job’s tears,” “fonio”
3 Impact of consuming millets on lipid profile
4. Efficacy of millets on total triacylglycerol levels in humans. Replaced
the word “total triacylglycerol” with “cholesterol,” “LDL-C,” “HDL-C,”
“VLDL-C”
Only studies that were published in the English language were
considered. The scoping study was conducted using PubMed
and MEDLINE to check for any existing studies on this topic
and whether there were any overlaps with the research question
as per the guidelines of (8). Search engines including Google
Scholar, Scopus, Web of Science, PubMed, and CAB abstract
were used to identify studies relevant to the research question.
Search results obtained through a search strategy and keywords
(Table 1) were further screened for relevance of the study,
completeness of information, and quality of research, based on
inclusion and exclusion criteria. If, after collecting the full papers,
any required data were missing, the authors of the papers were
contacted and complete information was requested for use in
the meta-analysis.
Inclusion Criteria
The PRISMAflow diagram (Figure 1) shows the steps involved in
the inclusion and exclusion of the studies. The articles published
between 2011 and the first quarter of 2021, which fulfilled the
criteria of being (1) Randomized controlled trials, self-controlled
clinical trials, and/or cross-sectional studies conducted to test
the efficacy of millets on TC, triacylglycerols, LDL-C, VLDL-
C, and/or HDL-C; (2) studies that had information on any
or all of the outcomes, including levels of TC, triacylglycerol,
LDL-C, VLDL-C, and HDL-C; (3) studies on any age group
or gender of any population to test the efficacy of millets
on blood lipid profile; (4) studies that assessed the effects of
millets on blood lipid profile along with or without weight,
BMI, and systolic and/or diastolic blood pressure; and (5) only
peer-reviewed journal articles were selected and included in the
current systematic review.
Exclusion Criteria
(1) Review articles were excluded from further consideration.
(2) Animal studies were excluded. (3) In the case of incomplete
data, the authors were contacted. If complete data were still not
accessed, the study was excluded.
Data Extraction
Each study was labeled with author details and year. The age
group and gender of the participants were recorded along with
the country, study method, sample size, type, and form of millets
studied. The numerical variables considered for analysis included
mean TC level, triacylglycerol, VLDL-C, LDL-C, and HDL-C
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FIGURE 1 | PRISMA flow diagram for systematic review.
in mg/dl, and weight gain or loss in kg. Systolic and diastolic
blood pressure was recorded in mmHg. The data were then
entered into Excel spread sheets as per guidelines provided
by Harrer et al. (9). If standard error was recorded, it was
converted to standard deviation (SD). Similarly, if the data
were presented in different units, they were converted to the
same unit to maintain uniformity. For example, cholesterol, and
triacylglycerol concentrations given in mmol/L were converted
to mg/dl to ensure the same unit of measurement is used for all
the measurements.
Quality Assessment of the Studies
Using the eight-item Newcastle–Ottawa Scale (10, 11), the
quality of each study was assessed by two investigators, and any
disagreement was resolved by discussing it with a third reviewer.
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FIGURE 2 | Effect of consuming millets on total cholesterol level (pre- vs. post-treatment or intervention vs. control diet).
The researchers also applied the principle of Bell et al. (12) to
further strengthen the quality assessment.
Risk of Bias Assessment
A funnel plot was used to assess publication bias if any. Other
biases such as selection bias, detection bias, attrition bias, and
reporting bias were assessed using the guidelines provided in
Cochrane Handbook online version 6.2, (2021) for systematic
reviews of interventions (13, 14).
Summary Measures and Result Synthesis
Groups of individuals who were fed with millet-based meals for
certain study periods (28 days to 4 months) were considered
as intervention groups. The initial baseline measurement taken
on these individuals was considered as the control measurement
or pre-intervention measures, which consisted of regular rice-
and wheat-based diets. Therefore, the before and after effects on
primary outcomes, such as HDL-C, VLDL-C, LDL-C, TC, and
triacylglycerol levels, and secondary outcomes such as weight,
BMI, and systolic and diastolic blood pressure were included
in the meta-analysis to measure the standard mean difference
(SMD) and heterogeneity (I2). The significance of the results was
determined using the fixed effect model for small samples, and/or
single-source information with low heterogeneity among studies,
and the random effect model for other cases (15, 16) and a p-
value<0.05 indicates the significance of the effect. Results of both
the fixed effect and random effect models were captured in each
forest plot. A meta-analysis was conducted using the software
R Studio version 4.0.4 (2021) to obtain forest plot along with
heterogeneity (I2) and the overall test effect in the fixed effect and
random effect models and funnel plots to determine publication
bias (9, 17).
Descriptive statistics results such as mean, SD, and a
percentage increase or decrease in TC, LDL-C, VLDL-C, HDL-
C, triacylglycerol, weight, BMI, and systolic and diastolic blood
pressure were calculated for both the intervention samples and
control samples.
Subgroup Analysis
Subgroup analysis was conducted for different types of millets
used in the study.
RESULTS
Finger millet, foxtail millet, barnyard millet, and/or a mixture
of millets (finger millet and little millet) were used in the 19
studies (18–36) that were included in one or more outcomes
of meta-analysis. It was observed that consumption of millet-
based food for a duration varying from 21 days to 4 months
had a significant reducing effect on TC, triacylglycerol, VLDL-C,
and/or LDL-C levels. Two cross-sectional studies included in the
systematic review documented millet consumption information
for up to 2 years. The consumption of millets was either in the
form of biscuits, burfi (sweet), porridge, buns, boiled with water
(similar to rice), roti (flatbread), dumpling, or upma. The amount
of millets provided to the intervention groups varied from 50 to
200 g (dry weight basis) either in one meal or divided into two
meals per day.
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FIGURE 3 | Effect of consuming millets on triacylglycerol level (pre- vs. post-treatment or intervention vs. control diet).
FIGURE 4 | Effect of consuming millets on low-density lipoprotein-cholesterol (LDL-C) level (pre- vs. post-treatment or intervention vs. control diet).
The meta-analysis conducted on an outcomes-generated
forest plot shows a significant reducing effect in TC levels after
the consumption of a millet-based diet for 21 days to 4 months
(p = 0.01) with SMD of −0.56, 95% class interval of −0.94
to −0.19, and I2 value of 89% confirming the heterogeneity
(Figure 2). Descriptive statistics conducted for 870 samples, and
21 observations from the 18 studies showed that the TC levels
decreased by 8% from 189.5± 27.7 to 174.8± 28.9 mg/dl. Three
Frontiers in Nutrition | www.frontiersin.org 5 August 2021 | Volume 8 | Article 700778
Anitha et al. Millet to Manage Blood Lipid Profile
FIGURE 5 | Effect of consuming millets on very-low–density lipoprotein-cholesterol (VLDL-C) level (pre- vs. post-treatment or intervention vs. control diet).
studies demonstrated the reduction in TC levels from 215.8 ±
12.5 mg/dl (>200 mg/dl hence hypercholesterolemia) to 167.5±
3.2 mg/dl (<200 mg/dl hence normal).
The consumption of millets for a period of 21 days to 2 years
had a significant reducing effect on (p < 0.01) triacylglycerol
levels with SMD of −0.38 and 95% confidence interval (CI) of
−0.47 to −0.28. As the heterogeneity was low (I2 = 45%), the
fixed effect model was used to interpret the results (Figure 3).
Nonetheless, in both the fixed effect and random effect models,
the effects were significant (p < 0.01). Descriptive statistics for
852 samples and 20 observations from the 17 studies showed a
decrease in triacylglycerol levels by 9.5% from 154.3 ± 24.5 to
139.8 ± 23.5 mg/dl. There were four studies that demonstrated
the reduction in hypertriacylglycerolemia (>150 mg/dl) to
normal triacylglycerol levels (<150 mg/dl) after consumption of
millets for 3 months with a mean reduction from 170.4± 17.2 to
128.6± 14.9 mg/dl (24.5% reduction) (18, 26, 28, 30).
The consumption ofmillet-based diets for long periods of time
also had a significant reducing effect (p < 0.01) on LDL-C levels
with I2 value of 72% (moderate heterogeneity among studies)
with SMD of −0.51 and 95% CI of −0.74 to −0.27 (Figure 4).
The LDL-C levels from 834 samples in 18 observations from
the 16 studies were 118.2 ± 23.9 mg/dl, compared with 106.7
± 25.4 mg/dl at the baseline (10% reduction). Particularly, five
studies demonstrated the reduction in LDL-C from a moderately
elevated level of 116.5 ± 10.0 to a normal level of 92.6 ± 8.7
mg/dl. One long-term cross-sectional study showed a reduction
from the high level of LDL-C (160.1 ± 26 mg/dl) to the
moderately high level (140.1± 16.5 mg/dl).
For VLDL-C meta-analysis, I2 value was 0% indicating no
heterogeneity between the studies. However, both the fixed effect
and random effect models showed a significant reducing effect
in VLDL-C levels with p<0.01 (Figure 5). It is evident from 521
samples, 12 observations of the 10 studies that VLDL-C levels
decreased by 9.0% from 30.2± 6.0 to 27.5± 4.9mg/dl.
In contrast to other outcomes, the HDL-C levels (Figure 6)
had a significant increasing effect after consumption of millet-
based foods for a long period (p < 0.01) with SMD of 0.32, 95%
CI of 0.12–0.52. Descriptive statistics showed that HDL-C levels
slightly increased (6.0%) from 43.4 ± 7.5 to 46.0 ± 7.6 as found
in 763 samples in 18 observations from the 15 studies.
The ratio of TC to HDL-C was kept below 5 (ideal) by
consuming barnyard millet–based meals for 28 days to two
months (32, 35), where the TC:HDL-C ratio was reduced from
5.1± 0.14 to 4.2± 0.26.
Although, descriptive statistics showed a mean reduction
in weight by 1.5 ± 0.4 kg among 208 study participants who
consumed the millet-based diet, the effect on reduction was
not statistically significant in a meta-analysis (p = 0.15). There
were only four studies that measured systolic blood pressure,
which showed a significantly reducing effect after consuming a
millet-based diet (p < 0.01). Diastolic blood pressure showed a
significantly reducing effect after consumption of millet-based
diet (p < 0.01). BMI had significantly reducing effect by 7.0%
after consumption ofmillet-based diets for 3–4months (p< 0.05)
with no heterogeneity observed among the studies (I2 = 0%) and
95% CI of−0.34 to−0.0.02 (Figures 7–10).
Publication bias was assessed using the funnel plot, and the
observed asymmetry was adjusted using the trim and fit model
to account for the small sample size effect until symmetry was
achieved (p < 0.0001).
DISCUSSION
Hypertension, hyperlipidemia, diabetes, and smoking are the
main risk factors for atherosclerotic CVD (37, 38). A recent
systematic review on the effects of millets in managing and
reducing the risk of developing type 2 diabetes showed that
millets have beneficial effects on diabetes by providing low GI
meals, reducing fasting and post prandial blood glucose levels
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FIGURE 6 | Effect of consuming millets on high-density lipoprotein-cholesterol (HDL-C) level (pre- vs. post-treatment or intervention vs. control diet).
FIGURE 7 | Effect of consuming millets on weight of the participants (pre- vs. post-treatment or intervention vs. control diet).
as well as the glycated hemoglobin level (HbA1c) (6). The
current systematic review focused on the effect on blood lipids
as another important beneficial outcome of millet consumption.
The meta-analysis showed that the ingestion of low (46.7 ±
12.0%) GI millet-based food had significant reductions in the
levels of TC, triacylglycerol, LDL-C, and VLDL-C. Among other
factors, the levels of glucose (and other simple carbohydrates)
and saturated fats, and inappropriately controlled diabetes and
metabolic syndromes are the causes of hyperlipidemia (37).
Millets, being a low-GI food (6), reduce the blood glucose
available for the synthesis of triacylglycerols (27). Moreover,
millets also reduced VLDL-cholesterol which is a carrier
of triacylglycerol in plasma, thereby it further reduced the
triacylglycerol levels. This implies that millets play a key role in
reducing triacylglycerol levels.
Overall, the 17 studies demonstrated an average of 9.5%
reduction in triacylglycerol levels, and particularly four of
the studies (18, 26, 28, 30) demonstrated that the plasma
triacylglycerol levels reduced from a hypertriglyceridemic (>150
mg/dl) condition to normal (<150 mg/dl) when a millet-based
meal was consumed once a day for 3 months instead of the
regular rice- and/or wheat-based diets. Although, two cross-
sectional studies that recorded more than 2 years of millet
consumption showed that there was a reduction (26, 28), further,
long-term randomized controlled trials would be necessary to
confirm this.
LDL-C is considered as a major risk factor for CVD
(39). Even with medication, residual LDL-C is associated
with the risk of CVD. In the current study, consuming
millets was shown to significantly reduce the LDL-C
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FIGURE 8 | Effect of consuming millets on BMI of the participants (pre- vs. post-treatment).
FIGURE 9 | Effect of consuming millets on systolic blood pressure of the participants (pre- vs. post-treatment or intervention vs. control diet).
FIGURE 10 | Effect of consuming millets on diastolic blood pressure of the participants (pre- vs. post-treatment or intervention vs. control diet).
levels, and long-term consumption resulted in efficient
reduction (26), indicating that long-term consumption of
millets can help manage LDL-C levels and reduce the risk
of CVD.
Reduction in the levels of LDL-C, VLDL-C, triacylglycerol,
and TC is associated not only with the consumption of low-
GI millets that produce a low glucose response and reduce
the availability of glucose for triacylglycerol formation (27),
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TABLE 2 | Fatty acid profile of the millets in comparison to other staple foods.
Type of grain Linoleic acida Oleic acidb Mono-unsaturated fatty acids Poly-unsaturated fatty acids Saturated fatty acids
(mg/100g) (mg/100g) (mg/100g) (mg/100g) (mg/100g)
Finger millet 362 ± 15 585 ± 36 585 ± 36 431 ± 21 317 ± 17
Pearl millet 1844 ± 57 585 ± 36 1047 ± 40 1984 ± 55 875 ± 35
Sorghum 508 ± 18 314 ± 14 314 ± 40 524 ± 18 163 ± 6
Kodo millet 576 ± 18 291 ± 7 297 ± 7 597 ± 18 246 ± 2
Little millet 1230 ± 43 868 ± 24 868 ± 24 1277 ± 48 589 ± 40
Maize, dry 1565 ± 18 700 ± 18 706 ± 17.4 1606 ± 18.5 413 ± 5.6
Rice, raw milled 234 ± 46 109 ± 21 117 ± 6.6 253 ± 13.2 184 ± 8.9
Wheat flour, refined 325 ± 7 51 ± 3 51 ± 3 343 ± 8 99 ± 2
Wheat flour, whole 697 ± 20 149 ± 8 149 ± 8 742 ± 19 206 ± 8
Source: Longvah et al. (40).
aEssential omega-6 fatty acid, beneficial for cardiovascular health, metabolism, and immune functions.
bA non-essential mono-unsaturated omega-9 fatty acid.
but also with the consumption of unsaturated fatty acids from
millets. The content of unsaturated fatty acids (both mono-
and poly-unsaturated) is 2–10 times higher in millets compared
with refined wheat and milled rice (Table 2). Some millets have
2.5, 5.7, and 7.8 times more unsaturated fatty acids, especially
poly-unsaturated fatty acids compared with milled rice, whole
wheat, and refined wheat. Intake of unsaturated fatty acids
helps maintain high HDL-C levels. In addition, intake of poly-
unsaturated fatty acids, which are essential in our diet, helps in
lowering LDL-C levels and thereby lowering the risk associated
with CVD (41, 42). Therefore, it suggests that replacing milled
rice and refined wheat flour with millets bearing low GI and
high poly-unsaturated fatty acids will help in reducing the risk of
CVD. In this systematic review, there was 6.0% increase in HDL-
C levels after consumption of millet-based meals as compared
with regular rice or wheat meals. Thus, there is a need for further
long-term randomized controlled trials to assess the impacts on
HDL-C levels over an extended period of time. It is also noted
that the refining process of teff, a type of millet, decreases the
unsaturated fatty acid content and increases the risk of CVD (43).
Diastolic hypertension is common in individuals with
components of the metabolic syndrome such as diabetes and
hyperlipidemia, and diastolic blood pressure is the best predictor
for future risk of CVD (44, 45). Five studies (18, 21, 22, 26,
28) showed that the average diastolic blood pressure in 320
subjects was slightly higher (86.9 ± 1.8 mmHg) than normal
(<80 mmHg) at the beginning of the intervention, which was
later decreased by 5% (from 86.9 ± 1.8 to 82.7 ± 1.3 mmHg),
along with a decrease in lipids, after consuming a millet-based
diet for 3 months compared with a regular rice/wheat-based
diet. This suggests that consumption of a millet-based diet and
diversification of staples with millet will help in reducing the risk
of hypertension and associated CVD.
Obesity is a major concern as it raises the risk of CVD and
type 2 diabetes. There was no statistically significant reduction in
weight observed in the meta-analysis (p = 0.15), although, there
was a reduction in the mean weight by 1.5 kg in 3 months. This
suggests that more long-term studies with a larger sample size
are needed for further investigation. Moreover, not all the studies
that reported BMI also reported the actual weight.
On the other hand, it was evident from eight studies that on
average there was a 7.0% reduction in BMI (28.5 ± 2.4 to 26.7
± 1.8 kg/m2) in initially overweight and obese people, showing
the possibility of returning to a normal BMI range (<25). Among
the eight studies, six were randomized controlled trials conducted
for 3–4 months, whereas, two others were cross-sectional studies
conducted for 1–2 years. In the randomized controlled trials,
there was no heterogeneity (I2 = 0.0%) observed between the
studies, which could be due to the smaller number of studies,
sample size, and the influence of geographical distribution (Asian
population, mostly Indian). Moreover, there was no variation in
effect size, with SMD of −0.18 for both fixed effect and random
effect models. The result was significant both in fixed effect
and random effect models (p < 0.05). Therefore, it was evident
that millet-based food consumption can help reduce the degree
of overweight and obesity (>30 BMI). In the open-label, self-
controlled clinical trial by Ren et al. (21), they observed that a
reduction in BMI to be associated with a significant reduction in
body fat mass (from 22.1± 7.1 to 21.1± 7.2 kg) within 12 weeks
of foxtail millet consumption compared with only regular diet
with no significant reduction in body muscle mass, indicating
that consumption of millet was particularly targeting the fat in
the body. Another study also showed a significant reduction in
body fat mass from 21.6± 0.96 to 20.92± 0.98 kg by consuming
whole foxtail millet-based meals for 12 weeks compared with a
regular diet (33).
Furthermore, studies also showed that consumption of millet-
based foods caused satiety (32). Ren et al. (21) showed that
consumption of foxtail millet for 12 weeks increased the blood
leptin levels significantly (from 8.3 ± 6.4 to 9.6 ± 7.0 ng/ml),
which is the indication of hunger suppression and reduced energy
intake by altering the nervous system signals and blood glucose
metabolism. The satiety is also due to slower gastric emptying
time (32, 46, 47) and the high fiber content of millet (40). This
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characteristic may reduce sudden spikes in blood glucose levels,
leading to decreased availability of glucose for triacylglycerol
synthesis, thereby reducing triacylglycerol levels. This would
need detailed research to further investigate and quantify the
variables and impacts.
Hyperlipidemia is associated with inflammation, leading
to lipotoxicity and progression of CVD. Some markers that
might contribute to endothelial dysfunction include leptin,
interleukin-6 (IL-6), and adiponectin. Potential tools for risk
assessment include serum high-sensitivity C-reactive protein
(hs-CRP), fasting insulin, tumor necrotic factor-α (TNF-α), IL-
6, leptin, and adiponectin (48). A study conducted on foxtail
millet consumption for 12 weeks (18) showed a decrease in
inflammatory marker IL-6 from 6.2 ± 9.4 to 4.8 ± 5.5 pg/ml
and TNF-α from 2.6 ± 5.5 to 1.4 ± 0.5 pg/ml. Another
study on finger millet consumption for 12 weeks (18) showed
a significant reduction in IL-6 (from 4.9 ± 0.7 to 1.60 ±
0.5 mmol/l) (p = 0.000) and TNF-α (from 7.8 ± 1.2 to 3.9
± 0.6 mmol/l) (p = 0.016). However, Sobhana et al. (22)
demonstrated that consumption of a millet-based diet for 3
months did not significantly reduce hs-CRP (from 0.45 ± 0.078
to 0.43 ± 0.064µg/ml), which is not a significant reduction.
More long-term studies are recommended to examine this effect.
However, the reduction in IL-6 and TNF-α suggests that millet
consumption can reduce inflammation caused by hyperlipidemia
and diabetes.
Two studies examined the impacts of millets consumption on
plasma antioxidant capacity. Hymavathi et al. (20) demonstrated
significant increases in the levels of antioxidants such as
superoxide dismutase from 79 ± 11 to 82 ± 12 U/ml, and
reduced glutathione (GSH) level from 10.9 ± 2 to 11.9 ± 2 U/L,
suggesting that consumption of fingermillet could suppress stress
levels in both diabetic and normal individuals. Consumption of
millets for 8 weeks increased the ferric ion–reducing antioxidant
power (19) from 679.5 ± 120.3 to 763.9 ± 105.3 (p < 0.05) and
Trolox equivalent antioxidant capacity from 296.9 ± 122.8 to
431.0 ± 55.4 (p < 0.05). In other words, antioxidant capacity
improved in healthy individuals upon consumption of millets.
Similar studies should be conducted on pre-diabetic, diabetic,
and hyperlipidemic individuals to understand the effects of tissue
damage from metabolic syndromes.
In this systematic review, although, studies examined the
impacts of millet consumption on blood lipid profile, none of
the included studies focused on millet consumption and its
impact on hyperlipidemia in other related disease conditions,
such as non-alcoholic fatty liver disease (NAFLD), which is
predicted to become a major cause of liver-related morbidity and
mortality by 2030 (49). Consumption of whole grains increases
the intake of unsaturated fatty acids and dietary fiber, which
enhances the fullness or satiety value, which, in turn, could have
a beneficial effect on reducing energy intake and hyperlipidemia,
and reducing the risk of CVD and NAFLD (49). Further,
research on long-term millet consumption and its association
with inflammatory markers and reduction in hyperlipidemia,
especially in NAFLD individuals, would help to construct dietary
plans to reduce risks of development and progression of NAFLD
and CVD.
Recommendations
Overall, it is recommended that millet-based diets be designed
and then promoted for management and prevention of
atherosclerotic CVD as well as weight management. It would
be beneficial to diversify major staples with millets across
Africa and Asia, because millets have nutritional and health
benefits, such as low GI and high levels of several necessary
micro- and macronutrients (e.g., iron, zinc, calcium, and
protein). Additionally, millets are a “smart food”: not only
“good for you” but also “good for the planet” and “good
for the farmer,” i.e., environmentally sustainable and climate-
smart, with a lower carbon footprint. Therefore, they should
also be part of solutions for reforming the food systems.
This will help contribute to a range of UN Sustainable
Development Goals, such as Zero Hunger, Good Health and
Well-being, Responsible Consumption and Production, and
Climate Action.
Priority research to address the limitations of this study or
build more evidence includes the following. (1) Only five millets
were assessed, namely finger millet, foxtail millet, barnyard
millet, sorghum, and little millet combined with other millets
in a meal. There are other millets and a range of varieties
that are grown globally and expected to bear similar effects
on managing hyperlipidemia. It is thus important to generate
evidence with the unstudied crops/varieties. (2) Out of the 19
studies, two were conducted in China, one in Sri Lanka, and one
in Brazil. The remaining 15 studies were from India, alluding
to a geographical limitation. Millets are grown and consumed
in all inhabited continents, especially across sub-Saharan Africa
and South Asia. It will be useful to generate further evidence
in different sub-populations. (3) The duration for randomized
controlled trials varied from 21 days to 4 months. Research over
a year or two will provide useful evidence. (4) No study was
conducted on the effects of processing and cooking of millets
on the lipid profile. It is critical to establish such a linkage. (5)
Only three studies determined TC to HDL-C ratio, which is a
key marker for CVD. Therefore, it is recommended to include
all relevant parameters while implementing dietary interventions
and assessing the impacts on hyperlipidemia and CVD. (6) The
number of products in each category (baking, boiling, etc) was
very small in the current systematic review hence the effect of
processing on lipid profile was not evaluated which could be
considered in future research. (7) As millets were identified to
reduce hyperlipidemia, millets are expected to have a role in
reducing or preventing NAFLD, which has not been studied
to date.
CONCLUSIONS
The systematic review executed in this study provides a strong
evidence that millet consumption can improve blood lipid profile
and thus exerts beneficial effects on management and prevention
of hyperlipidemia, reduction in high blood pressure, weight, and
BMI as well as an overall reduction in associated risk of CVD.
Millets should therefore be integrated into nutrition and health
strategies, utilized to diversify staples across Africa and Asia, and
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promoted as broader solutions in food system reforms. Further,
analysis, customized to the situation, should be undertaken to
ensure that millets are appropriately integrated into initiatives for
maximized effectiveness.
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